Company Information

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1739.80-17.65 (-1 %)
PREV CLOSE ( ) 1757.45
OPEN PRICE ( ) 1768.20
BID PRICE (QTY) 1739.10 (16)
OFFER PRICE (QTY) 1739.80 (4)
VOLUME 6877
TODAY'S LOW / HIGH ( )1736.05 1777.55
52 WK LOW / HIGH ( )861.5 2195.75
NSE1739.30-17.4 (-0.99 %)
PREV CLOSE( ) 1756.70
OPEN PRICE ( ) 1770.00
BID PRICE (QTY) 1739.20 (58)
OFFER PRICE (QTY) 1739.95 (2)
VOLUME 57324
TODAY'S LOW / HIGH( ) 1737.15 1780.80
52 WK LOW / HIGH ( )861 2194
ChairmanYiu Kwan Stanley Lau
Managing DirectorSrinivas Sadu
Company SecretaryP Sampath Kumar
Non Executive Independent DirectorNaina Lal Kidwai
Udoj J Vetter
Satyanarayana Murthy Chavali
Essaji Goolam Vahanvati
Non Independent & Non Executive DirectorQiyu Chen
Yao Fang
Allen Zhang
Incorporation Year : 20-03 1978

Registered Office :

Address : Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District Hyderabad,
Telangana-500043 .

Phone : 040 30510999

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.